Researchers said that he prevalence of diabetes and impaired glucose tolerance is high in women with polycystic ovary syndrome (PCOS), the most frequent endocrine disorder in women, according to a study in the latest Medical Journal of Australia.
Professor Robert Norman and his co-authors from the Research Centre for Reproductive Health at The University of Adelaide, examined the case records of 660 women attending a reproductive endocrine clinic at the Adelaide University Research Centre for treatment of infertility or features of PCOS.
“The prevalence of glucose intolerance abnormalities is high in women with PCOS, especially in older women and those with abdominal obesity and a family history of diabetes,” Prof Norman says.
In a related editorial in the Journal, Prof Helena Teede, Director of Research at Jean Hailes Foundation and Head Diabetes at Southern Health in Melbourne, and her co-author, Assoc Prof Bronwyn Stuckey, a physician at the Department of Endocrinology and Diabetes at Sir Charles Gairdner Hospital in Perth, say a greater understanding of appropriate screening for PCOS, long-term risks, and effective interventions is urgently needed.
“Prevention and treatment strategies should also be more aggressively pursued in these higher risk subgroups.” Prof Teede adds that realistic and achievable changes in lifestyle through sustainable multidisciplinary approaches with realistic goals (5-10 per cent loss of weight) can significantly contribute to treatment of PCOS and the prevention of diabetes in women with PCOS.